Rare diseases
Investigational molecules
Locations
Study on the Safety and Effectiveness of Azetukalner for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications
GermanyStudy of Belantamab Mafodotin for Patients with Relapsed or Refractory AL Amyloidosis
FranceStudy of AMG 193 alone and combined with docetaxel for treatment of advanced MTAP-null solid tumors in adult patients
AustriaStudy on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)
BelgiumStudy on Gene Therapy for Pyruvate Kinase Deficiency Using Autologous CD34+ Cells in Adults and Children
SpainStudy on the Safety and Effectiveness of Crofelemer for Children with Microvillus Inclusion Disease (MVID)
ItalyStudy on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer
BelgiumStudy on the Effectiveness of Lenvatinib for Patients with Advanced Gastrointestinal Stromal Tumors After Imatinib and Sunitinib Treatment Failure
FranceStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections
CroatiaStudy on the Effects of Topical Sirolimus for Lingual Microcystic Lymphatic Malformations in Children and Adults
FranceStudy Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement
AustriaStudy on Tafasitamab with Gemcitabine, Oxaliplatin, and Rituximab for Patients with Aggressive B-cell Lymphoma
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
